Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
| NCT ID | NCT02574533 |
| Title | Pilot Study of Vigil + Pembrolizumab for Advanced Melanoma |
| Recruitment | Completed |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | Gradalis, Inc. |
| Indications | |
| Therapies | |
| Age Groups: | adult |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Texas Oncology P.A., Texas Cancer Center | Abilene | Texas | 79606 | United States | Details | |
| Mary Crowley Medical Research Centers | Dallas | Texas | 75230 | United States | Details | |
| Cancer Care Northwest | Spokane | Washington | 99202 | United States | Details |